BETA

13 Amendments of Pilar DEL CASTILLO VERA related to 2018/0225(COD)

Amendment 240 #
Proposal for a decision
Recital 5 a (new)
(5 a) Horizon Europe gives high importance to the links between inclusive societies, R&I and societal challenges. The gender dimension is crucial to design inclusive societies as well as to produce responsible R&I, and constitutes a societal challenge in itself as stated in the UN Sustainable Development Goals. Gender impact should be addressed in any social and industrial transformation. This requires ensuring that gender will be appropriately integrated in all the instruments of Horizon Europe, from pillars, misions, clusters or international cooperation, to open science and open data.
2018/09/12
Committee: ITRE
Amendment 395 #
Proposal for a decision
Article 3 – paragraph 1 – point 3 – point a a (new)
(a a) SME Instrument for incremental innovation, as described in Annex I, Pillar III, section 1a;
2018/09/12
Committee: ITRE
Amendment 499 #
Proposal for a decision
Article 9 – paragraph 4 a (new)
4 a. The Commission shall ensure close cooperation between EIT KICs the wider Framework Programme.
2018/09/12
Committee: ITRE
Amendment 522 #
Proposal for a decision
Article 10 – paragraph 3 – subparagraph 3 a (new)
The European Parliament shall be informed and consulted before the appointment of the President and the members of the EIC Board.
2018/09/12
Committee: ITRE
Amendment 766 #
Proposal for a decision
Annex I – part II – point 1 – point 1.1 – paragraph 4 a (new)
Digital health solutions has created many opportunities to solve the problems of care services and to address the other emerging issues of ageing society. Digital devices and software have been developed to diagnose and treat illness and chronic disease, facilitate the self-management of chronic diseases and help people monitor their bodily functions and activities. Digital technologies are increasingly used in medical training and education and for patients and other healthcare consumers to access, share and create health information.
2018/09/12
Committee: ITRE
Amendment 782 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.1 – paragraph 1 – subparagraph 1 (new)
The Commission shall support a necessity for improving patient adherence model which is based on the most stable findings from meta-analyses and large-scale empirical studies, reflects the realities of medical practice and offers recommendations for assessing and enhancing patient adherence, particularly in chronic disease management. The adherence model is a key modern factor for measuring the efficiency and effectiveness of the healthcare systems
2018/09/12
Committee: ITRE
Amendment 812 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.2 – paragraph 1 a (new)
Healthcare professionals and a patient- centric imperative have to be at the centre of all digital innovation, which contains: full implementation of all possible new technologies, well designed physicians preparation, improved organisational systems using new digital instruments, openness of all partners of healthcare for innovative solutions.
2018/09/12
Committee: ITRE
Amendment 867 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.5 – paragraph 1
Health technologies and tools are vital for public health and contributed to a large extent to the important improvements achieved in the quality of life, health and care of people, in the EU. It is thus a key strategic challenge to design, develop, deliver and implement suitable, trustable, safe, and cost-effective tools and technologies for health and care, taking due account of the needs of people with disabilities and the aging society. These include artificial intelligence, big data, quantum technology, cloud and other digital technologies, offering significant improvements over existing ones, as well as stimulating a competitive and sustainable health-related industry that creates high-value jobs. The European health-related industry is one of the critical economic sectors in the EU, accounting for 3% of GDP and 1.5 million employees.
2018/09/12
Committee: ITRE
Amendment 889 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.6 – paragraph 1
Health systems are a key asset of the EU social systems, accounting for 24 million employees in the health and social work sector in 2017. It is a main priority to render health systems accessible, cost- effective, resilient, sustainable and trusted as well as to reduce inequalities, including by unleashing the potential of data-driven and digital innovation for better health and person-centred care building on open European data infrastructures. This will advance the digital transformation of health and care. The future infrastructure should rely on secure storages, 5G deployment, conditions for IoT development, processing healthcare Big Data in High Performance Computing Centres.
2018/09/12
Committee: ITRE
Amendment 902 #
Proposal for a decision
Annex I – part II – point 1 – point 1.2 – point 1.2.6 – paragraph 2 – indent 6
– Improving timely health information and use of health data, including electronic health records, with due attention to security, trust, privacy, interoperability, standards, comparability and integrity;
2018/09/12
Committee: ITRE
Amendment 1818 #
Proposal for a decision
Annex I – part III – point 1 – point 1.1 – point 1.1.1 – paragraph 4
These portfolios of selected projects25 will be further developed and enhanced, each along a vision developed with their innovators, but also shared with the research and innovation community at large. The Pathfinder's Transition activities will be implemented to help innovators develop the pathway to commercial development, such as demonstration activities and feasibility studies to assess potential business cases, and support the creation of spin offs and startups. These Pathfinder's Transition activities may also consist of complementary grants to top-up or enlarge the scope of previous and on- going actions, to bring in new partners, to enable collaboration within the portfolio and to develop its multidisciplinary community. _________________ 25 These may also include projects selected under Horizon 2020 programmes such as FET. These may also include other EU supported relevant activities and funded Seal of Excellence stemming from Pathfinder calls.deleted
2018/09/12
Committee: ITRE
Amendment 1841 #
Proposal for a decision
Annex I – part III – point 1 – point 1.1 – point 1.1.2 – paragraph 8
The Accelerator will allow for fast-track take-upencourage applications of innovations stemming from Pathfinder-supported projects from the Pathfinder, from Phase 1 and 2 of SME Instrument for Incremental Innovation, from similar Member States 'advanced research programmes' and from other pillars of the EU Framework Programmes28 , in order to support them to reach the market. This identification of projects supported in other pillars of Horizon Europe and also previous Framework Programmes will be based on pertinent methodologies, such as the Innovation Radar. _________________ 28 projects supported under the 'Global Challenges and Industrial Competitiveness" Pillar, startups emerging from the KICs of the European Institute of Innovation and Technology, … Including from Horizon 2020 activities, particularly project selected under Horizon 2020 SME Phase 2 and related Seal of Excellence financed by Member States, (existing and future) European Partnerships.Such as ERC Proof of Concept, from
2018/09/12
Committee: ITRE
Amendment 1871 #
Proposal for a decision
Annex I – part III – point 1 a (new)
1 a. SME INSTRUMENT FOR INCREMENTAL INNOVATION 1.1. Rationale SME as defined in article 2 of Annex I of Commission Recommendation 2003/361/EC make up over 99 % of all enterprises in all EU countries and in Norway. They account for around two- thirds of total employment, ranging from 53 % in the United Kingdom to 86 % in Greece. SME contribute 57 % of value added in the EU.SME are thus a very important part of the European economy. Mostly of these SME do not develop breakthrough ideas but incremental innovation that is necessary for the continuous progress of society. Also, there are many SME in the EU (i.e. newly created spin off and start ups) without economic history that allow them to be recipients of a loan, so an instrument dedicated only to SME and consisting only on grants, is still needed. Therefore, this SME instrument for incremental innovation shall continue to provide staged and seamless support to innovative SME. The SME instrument shall be targeted at innovative SME showing a strong ambition to develop, grow and internationalise. It shall be provided for incremental innovation, including service, non-technological and social innovations, given each activity has a clear European added value. Only SME will be allowed to apply for funding and support. They can form collaborations according to their needs, including for subcontracting research and development work. Projects must be of clear interest and potential benefit to SME and have a clear European dimension. 1.2.Areas of intervention and implementation The SME instrument for incremental innovation will cover all fields of science, technology and innovation in a bottom-up approach so as to leave sufficient room for all kinds of incremental innovation ideas, notably cross-sector and interdisciplinary projects, to be funded. It will operate under a single centralised management system, light administrative regime and a single entry point. It shall be implemented in a bottom-up manner through a continuously open call, with four cut-off per year. The SME instrument for incremental innovation will provide simplified and staged support in three phases. Its three phases will cover the whole innovation cycle. Transition from one phase to the next will be seamless, provided that the SME project has proven to be worth further funding during a previous phase. There is no obligation for applicants to sequentially cover all three phases. At the same time each phase will be open to all SME: – Phase 1:Concept and feasibility assessment: SME will receive funding to explore the scientific or technical feasibility and the commercial potential of a new idea (proof of concept) in order to develop an incremental innovation project. A positive outcome of this assessment, in which the linkage between project-topic and potential user/buyer needs is an important issue, will allow for funding under the following phase(s). - Phase 2:R&D, demonstration, market replication: With due attention to the innovation voucher concept, research and development will be supported with a particular focus on demonstration activities (testing, prototype, scale-up studies, design, piloting innovative processes, products and services, validation, performance verification etc.) and market replication encouraging the involvement of end users or potential clients. Innovation Vouchers will promote the participation of young entrepreneurs. Phase 3:Commercialisation:This phase will fall under the EIC Accelerator established in article 43 of Regulation (XXXXX). Free-of-charge business coaching shall be provided as an optional service in Phases I and II to support and enhance the firm’s innovation capacity and help align the project to strategic business needs.
2018/09/12
Committee: ITRE